ESG

With a major new investment, Cognito Therapeutics is pushing its non-invasive light and sound therapy for Alzheimer's toward a 2027 market launch.

A new acquisition in data center alley reveals how investors are profiting from the AI boom by betting on the crucial, but overlooked, support infrastructure.

BioRestorative Therapies is leveraging its clinical-grade regenerative medicine to disrupt the aesthetics industry. Can science beat marketing?

A new survey finds AI makes procurement teams 3.7x more resilient, yet many leaders are held back by a dangerous overconfidence in their own knowledge.

A new FDA program offers a lifeline for patients with rare ROSAH syndrome, accelerating Drug Farm's promising first-in-class therapy.

A new survey reveals over half of Americans delay healthcare, creating a 'health debt' crisis fueled by cost fears and scheduling conflicts for younger generations.

A new partnership between Always and The Fibroid Foundation aims to break the silence on heavy periods and fibroids, combining product innovation with advocacy.

Starton Therapeutics files patents to combine its continuous low-dose therapy, STAR-LLD, with CAR-T, aiming to enhance cancer-killing power and durability.

Taiwanese biotech GNTbm's oral drug GNTbm-38, which turns 'cold' tumors 'hot', will begin Phase 1 trials for advanced and refractory cancers.

Iconic Australian bootmaker R.M.Williams expands its partnership with Bamboo Rose, leveraging AI-powered planning to modernize its global operations.

AI drug discovery firm Proxima appoints three titans of science to its board, signaling a major push in proximity therapeutics to rewrite medicine's rules.

With no approved treatments for the deadly pregnancy complication preeclampsia, one company's novel drug is now advancing to a crucial new clinical trial.

The biotech firm accelerates a key trial but faces a partner loss, widening losses, and a CEO search, putting its promising siRNA pipeline at a crossroads.

Investors watch closely as CytoSorbents balances a push for profitability with high-stakes regulatory hurdles for its life-saving blood purification tech.

Investors eye Moody's CEO Rob Fauber's upcoming speech for insights on AI strategy, M&A forecasts, and navigating an increasingly complex global economy.

With mixed trial results for its obesity drug and rising costs, Skye Bioscience's upcoming 2025 earnings call is a pivotal moment for investors.

Houston's largest credit union wins its second Gallup award in three years. We explore the strategy connecting happy employees to a thriving bottom line.

1 Hotel Tokyo debuts in Akasaka, fusing biophilic design with Japanese craft to set a new standard for planet-first luxury and holistic wellness.

A landmark partnership between Pivot Energy and Microsoft invests in communities, starting with $400,000 in Maryland, tying solar power to local jobs and resilience.

The Rockefeller Foundation expands its Mission 300 Fellowship, embedding experts in 18 African nations to accelerate electrification and clean cooking access.